Ha habido 50 transacciones internas recientes registradas para Tyme Technologies, Inc. (TYME), incluyendo 16 compras y 33 ventas. El total de compras internas fue valorado en $146.54K y el total de ventas internas en $815.57K.
Internos destacados con actividad reciente incluyen Tyson Timothy, Carberry David, Degolyer Donald W. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TYME
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2022-09-16 |
Tyson Timothy |
Director |
Devolución de Acciones |
88,000 |
$0.31 |
$27.28K |
- |
| 2022-09-16 |
Carberry David |
Director |
Devolución de Acciones |
88,000 |
$1.10 |
$96.8K |
- |
| 2022-09-16 |
Degolyer Donald W |
Director |
Devolución de Acciones |
88,000 |
$0.31 |
$27.28K |
- |
| 2022-09-16 |
Hoffman Steve |
10 Percent Owner |
Devolución de Acciones |
88,000 |
$0.31 |
$27.28K |
- |
| 2022-09-16 |
Galaini Barbara |
See Remarks |
Devolución de Acciones |
258,300 |
$0.32 |
$82.66K |
- |
| 2022-08-24 |
Hoffman Steve |
Director |
Concesión de RSU |
88,000 |
- |
- |
88,000 |
| 2022-08-24 |
Tyson Timothy |
Director |
Concesión de RSU |
88,000 |
$0.31 |
$27.28K |
88,000 |
| 2022-08-24 |
Michels Douglas A |
Director |
Concesión de RSU |
88,000 |
- |
- |
88,000 |
| 2022-08-24 |
Carberry David |
Director |
Concesión de RSU |
88,000 |
- |
- |
88,000 |
| 2022-08-24 |
Degolyer Donald W |
Director |
Concesión de RSU |
88,000 |
$0.31 |
$27.28K |
88,000 |
| 2022-08-24 |
Sokol Gerald H |
Director |
Concesión de RSU |
88,000 |
- |
- |
88,000 |
| 2022-08-24 |
Baker Christine D. |
Director |
Concesión de RSU |
88,000 |
- |
- |
88,000 |
| 2022-06-22 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.27 |
$21.09K |
20,022,566 |
| 2022-06-21 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.26 |
$20.31K |
20,100,691 |
| 2022-06-09 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.27 |
$21.09K |
20,178,816 |
| 2022-06-08 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.27 |
$21.09K |
20,256,941 |
| 2022-05-25 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.24 |
$18.75K |
20,335,066 |
| 2022-05-10 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.28 |
$21.88K |
20,491,316 |
| 2022-05-09 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.31 |
$24.22K |
20,569,441 |
| 2022-04-28 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.32 |
$25K |
20,647,566 |
| 2022-04-27 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.32 |
$25K |
20,725,691 |
| 2022-04-25 |
Cunningham, Richard Anthony |
Chief Executive Officer |
Concesión de RSU |
1,326,000 |
- |
- |
1,326,000 |
| 2022-04-22 |
Biehl James |
Chief Legal Officer |
Concesión de RSU |
482,200 |
- |
- |
482,200 |
| 2022-04-22 |
Eckard Jonathan |
Chief Business Officer |
Concesión de RSU |
482,200 |
- |
- |
482,200 |
| 2022-04-22 |
Galaini Barbara |
See Remarks |
Concesión de RSU |
258,300 |
$0.32 |
$82.66K |
258,300 |
| 2022-04-22 |
Van Tornout Jan M |
Acting Chief Medical Officer |
Concesión de RSU |
240,000 |
- |
- |
240,000 |
| 2022-04-22 |
Porfido Frank L. |
Chief Financial Officer |
Concesión de RSU |
396,800 |
- |
- |
396,800 |
| 2022-04-11 |
Hoffman Steve |
Director |
Venta Informativa |
78,125 |
$0.32 |
$25K |
20,803,816 |
| 2022-03-29 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.36 |
$27.8K |
20,960,066 |
| 2022-03-28 |
Hoffman Steve |
Chief Science Officer |
Venta Informativa |
78,125 |
$0.36 |
$27.8K |
20,960,066 |
| 2022-03-28 |
Hoffman Steve |
10 Percent Owner |
Venta Informativa |
78,125 |
$0.34 |
$26.77K |
21,038,191 |
| 2022-03-23 |
Baker Christine D. |
Director |
Desconocido |
- |
- |
- |
- |
| 2022-03-23 |
Baker Christine D. |
Director |
Concesión de RSU |
176,000 |
- |
- |
176,000 |
| 2022-03-10 |
Hoffman Steve |
Chief Science Officer |
Venta Informativa |
78,125 |
$0.31 |
$24.22K |
21,116,316 |
| 2022-02-28 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.31 |
$6.12K |
23,808,846 |
| 2022-02-25 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.30 |
$23.44K |
21,272,566 |
| 2022-02-24 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.29 |
$22.66K |
21,350,691 |
| 2022-02-22 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.32 |
$6.46K |
23,828,846 |
| 2022-02-17 |
Van Tornout Jan M |
Acting Chief Medical Officer |
Compra Informativa |
7,022 |
$0.36 |
$2.53K |
9,831 |
| 2022-02-15 |
Biehl James |
Chief Legal Officer |
Compra Informativa |
20,000 |
$0.34 |
$6.8K |
105,000 |
| 2022-02-14 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.33 |
$6.53K |
23,848,846 |
| 2022-02-08 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.36 |
$28.13K |
21,428,816 |
| 2022-02-07 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.36 |
$7.12K |
23,868,846 |
| 2022-02-07 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.36 |
$28.13K |
21,506,941 |
| 2022-01-31 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.34 |
$6.71K |
23,888,846 |
| 2022-01-26 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.34 |
$26.56K |
21,585,066 |
| 2022-01-25 |
Hoffman Steve |
10 Percent Owner, Officer: Chief Science Officer |
Venta Informativa |
78,125 |
$0.51 |
$39.84K |
21,663,191 |
| 2022-01-24 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.52 |
$10.4K |
23,908,846 |
| 2022-01-20 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
320 |
$0.59 |
$188.80 |
23,928,846 |
| 2022-01-10 |
Demurjian Michael |
10 Percent Owner |
Venta Informativa |
20,000 |
$0.60 |
$11.94K |
23,929,166 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento